• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Echo Therapeutics Inc

+ Add to Watchlist

ECTE:US

2.1220 USD 0.0120 0.57%

As of 10:26:53 ET on 07/10/2014.

Snapshot for Echo Therapeutics Inc (ECTE)

Open: 2.1000 Day's Range: 2.1000 - 2.1220 Volume: 1,142
Previous Close: 2.1100 52wk Range: 1.5300 - 4.9100 1-Yr Rtn: -14.78%

Stock Chart for ECTE

No chart data available.
  • ECTE:US 2.1220
  • 1D
  • 1M
  • 1Y
2.1100
Interactive ECTE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ECTE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5720
Est. EPS (USD) (12/2014) -0.8750
Est. PEG Ratio -
Market Cap (M USD) 25.28
Shares Outstanding (M) 11.98
30 Day Average Volume 77,626
Price/Book (mrq) 1.3421
Price/Sale (ttm) 194.9007
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ECTE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ECTE

Echo Therapeutics Inc. is a specialty transdermal therapeutics and diagnostics company. The Company develops portfolio of topical formulations of established, FDA approved products using its proprietary Azone dermal penetration technology.

Robert F Doman "Bob"ChairmanKimberly A BurkeInterim CEO/Chief Compliance Ofcr
Christopher P Schnittker "Chris"Senior VP/CFO/TreasurerKenneth Gary "Ken"Senior VP:Rsch & Ops
More Company Profile & Key Executives for ECTE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil